Innovations in drug-eluting stents

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomaterials Science

Background:

• Coronary artery disease (CAD) is a leading cause of global morbidity and mortality.
• Historically, surgical interventions were standard for CAD; the 1970s introduced percutaneous balloon angioplasty, a minimally invasive approach.
• Balloon angioplasty faced limitations like acute vessel closure and restenosis.

Purpose of the Study:

• To review the historical evolution of intracoronary stents for CAD treatment.
• To discuss the current use and limitations of drug-eluting stents (DES).
• To explore future research directions, including bioabsorbable stents and polymers.

Main Methods:

• This is a comprehensive review article.
• It synthesizes existing literature on the development and application of coronary stents.
• The review covers historical context, current technologies, and future trends.

Main Results:

• Bare metal stents and subsequently DES significantly advanced interventional cardiology, enabling treatment of complex lesions.
• DES have improved patient outcomes but present challenges such as delayed endothelialization and polymer-related issues.
• Limitations of current DES necessitate further innovation.

Conclusions:

• Coronary stent technology has progressed from basic scaffolds to sophisticated drug-eluting devices.
• Despite advancements, limitations in DES persist, highlighting the need for improved stent designs.
• Future research focuses on bioabsorbable materials to overcome current stent-related complications and enhance long-term patient outcomes.